High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation

High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Leukemia 2005-06, Vol.19 (6), p.1102-1103
Hauptverfasser: Shimazaki, C, Uchida, R, Nakano, S, Namura, K, Fuchida, S-i, Okano, A, Okamoto, M, Inaba, T
Format: Artikel
Sprache:eng
Schlagworte:
Alkaline phosphatase
Alkaline Phosphatase - blood
Antineoplastic Agents - administration & dosage
Biomedical materials
Boronic Acids - administration & dosage
Bortezomib
Cancer Research
Cell Differentiation - drug effects
correspondence
Critical Care Medicine
Hematology
Humans
Intensive
Internal Medicine
Male
Medicine
Medicine & Public Health
Middle Aged
Multiple myeloma
Multiple Myeloma - complications
Multiple Myeloma - drug therapy
Oncology
Osteoblastogenesis
Osteoblasts - cytology
Osteoblasts - drug effects
Osteoblasts - enzymology
Pyrazines - administration & dosage
Spinal Fractures - complications
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:0887-6924
1476-5551
DOI:10.1038/sj.leu.2403758